Related Topics News -

     
 Detail   |   Print 
     
復星國際:復星醫藥減持印度注射劑藥品生產製造公司6%股權 套現2.94億美元
2026-09-07T  
《大行》花旗升復星國際目標價至6.3元 潛在上市縮減資產淨值折讓
2026-08-31T  
《新股》復星就分拆度假村業務ClubMed上市提交上市申請
2026-08-31T  
《業績》復星國際中期純利升1.6倍至17.21億人幣
2026-08-27T  
復星國際附屬豫園半年賺1.62億人民幣 增長157.2%
2026-08-20T  
復星國際半日升7.4% 花旗料中期盈利向好推動股價表現
2026-07-30T  
《大行》花旗將復星國際加入30天上行短期觀察
2026-07-30T  
《盈喜》復星國際料中期純利按年增最多172%
2026-07-29T  
《新盤》復星清水灣邵氏片場項目進行開工奠基儀式 涉約40幢逾800伙
2026-06-29T  
《新股》復星醫藥擬分拆復星安特金於主板上市
2026-06-29T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.